Groupe Bruxelles Lambert (HAM:EAI) Research & Development: €0 Mil (TTM As of Dec. 2025)


HAM:EAI Groupe Bruxelles Lambert SA HAM:EAI
68 GF Score
Price €78.50
GF Value €76.55
! 8 Warning Signs
View Full Analysis

What is Groupe Bruxelles Lambert Research & Development?

Groupe Bruxelles Lambert HAM:EAI -1.75% 68 Research & Development is €0 Mil as of Dec. 2025. GuruFocus rates HAM:EAI with a GF Score™ of 68/100 and a GF Value™ of €76.55. The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Groupe Bruxelles Lambert's Research & Development for the three months ended in Dec. 2025 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0 Mil.

Groupe Bruxelles Lambert  (HAM:EAI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Groupe Bruxelles Lambert Research & Development Related Terms

Groupe Bruxelles Lambert Research & Development Historical Data

* Premium members only.

The historical data trend for Groupe Bruxelles Lambert's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Groupe Bruxelles Lambert Research & Development Chart

Groupe Bruxelles Lambert Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.00 42.00 44.00 41.00 43.00

Groupe Bruxelles Lambert Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HAM:EAI
68GF Score
Groupe Bruxelles Lambert SA HAM:EAI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Groupe Bruxelles Lambert Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Groupe Bruxelles Lambert (HAM:EAI) has a Research & Development of €0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Groupe Bruxelles Lambert and its competitors.
Is Groupe Bruxelles Lambert's Research & Development too high?
Groupe Bruxelles Lambert's current Research & Development is €0 Mil. Overall, Groupe Bruxelles Lambert has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Groupe Bruxelles Lambert's Research & Development compare to BLK and BX?
Groupe Bruxelles Lambert's Research & Development of €0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Groupe Bruxelles Lambert and its competitors. Groupe Bruxelles Lambert's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Groupe Bruxelles Lambert stock overvalued right now?
Groupe Bruxelles Lambert (HAM:EAI) has a current Research & Development of €0 Mil. The stock's GF Value™ is €76.55, compared to a current price of €78.50 — trading 2.5% above its estimated fair value. The current Research & Development is €0 Mil. Groupe Bruxelles Lambert's overall GF Score™ is 68/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Groupe Bruxelles Lambert (HAM:EAI), the current Research & Development is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Groupe Bruxelles Lambert (HAM:EAI) Overvalued in 2026?

Based on GuruFocus' analysis, Groupe Bruxelles Lambert stock appears to be overvalued. The current stock price of €78.50 is trading 2.5% above its estimated GF Value™ of €76.55.

Key valuation signals for HAM:EAI:

  • Research & Development: €0 Mil
  • GF Value™: €76.55 vs. price of €78.50 (2.5% above fair value)
  • GF Score™: 68/100 with 8 warning signs

No single metric tells the full story. See the HAM:EAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Groupe Bruxelles Lambert Business Description

Address 24, Avenue Marnix, Brussels, BEL, B-1000
Groupe Bruxelles Lambert SA is an investment holding company. The company operates as a foremost investor in Europe, focused on long-term value creation. The business activities of the firm are operated through Holding, Imerys, Webhelp/Sapiens, Canyon/GfG CapitaL, and Sienna Investment Managers. Geographically, it derives a majority of its revenue from Europe and also has a presence in Asia-Oceania, North America, and other countries. The segments of the company are Holding, Imerys, Canyon, Affidea, Sanoptis, and others.
68GF Score

Get the complete analysis for HAM:EAI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€78.50
Price
€76.55
GF Value